238 related articles for article (PubMed ID: 21328275)
41. A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results.
Argyriou AA; Chroni E; Koutras A; Iconomou G; Papapetropoulos S; Polychronopoulos P; Kalofonos HP
Support Care Cancer; 2006 Nov; 14(11):1134-40. PubMed ID: 16622646
[TBL] [Abstract][Full Text] [Related]
42. Cryocompression to Reduce Peripheral Neuropathy in Gynecologic Cancer: A Randomized Controlled Trial.
Anastasio MK; Unnithan S; Scott A; Hayes T; Shah S; Moss HA; Erkanli A; Havrilesky LJ
Obstet Gynecol; 2023 Dec; 142(6):1459-1467. PubMed ID: 37883997
[TBL] [Abstract][Full Text] [Related]
43. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2006 Apr; (2):CD002827. PubMed ID: 16625561
[TBL] [Abstract][Full Text] [Related]
44. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial.
Pace A; Bove L; Jandolo B
Neurology; 2005 Aug; 65(3):501-2; author reply 501-2. PubMed ID: 16087937
[No Abstract] [Full Text] [Related]
45. Chinese herbal medicine for diabetic peripheral neuropathy.
Chen W; Zhang Y; Liu JP
Cochrane Database Syst Rev; 2011 Jun; (6):CD007796. PubMed ID: 21678369
[TBL] [Abstract][Full Text] [Related]
46. Interventions for treating anxiety after stroke.
Knapp P; Campbell Burton CA; Holmes J; Murray J; Gillespie D; Lightbody CE; Watkins CL; Chun HY; Lewis SR
Cochrane Database Syst Rev; 2017 May; 5(5):CD008860. PubMed ID: 28535332
[TBL] [Abstract][Full Text] [Related]
47. Venlafaxine for neuropathic pain in adults.
Gallagher HC; Gallagher RM; Butler M; Buggy DJ; Henman MC
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011091. PubMed ID: 26298465
[TBL] [Abstract][Full Text] [Related]
48. A randomized, multicenter, double-blind, placebo-controlled, dose-finding study of ORG 2766 in the prevention or delay of cisplatin-induced neuropathies in women with ovarian cancer.
Roberts JA; Jenison EL; Kim K; Clarke-Pearson D; Langleben A
Gynecol Oncol; 1997 Nov; 67(2):172-7. PubMed ID: 9367703
[TBL] [Abstract][Full Text] [Related]
49. Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup.
Kerckhove N; Busserolles J; Stanbury T; Pereira B; Plence V; Bonnetain F; Krakowski I; Eschalier A; Pezet D; Balayssac D
BMJ Open; 2019 Jun; 9(6):e027770. PubMed ID: 31182448
[TBL] [Abstract][Full Text] [Related]
50. Decompressive surgery of lower limbs for symmetrical diabetic peripheral neuropathy.
Chaudhry V; Russell J; Belzberg A
Cochrane Database Syst Rev; 2008 Jul; 2008(3):CD006152. PubMed ID: 18646138
[TBL] [Abstract][Full Text] [Related]
51. The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial.
Kottschade LA; Sloan JA; Mazurczak MA; Johnson DB; Murphy BP; Rowland KM; Smith DA; Berg AR; Stella PJ; Loprinzi CL
Support Care Cancer; 2011 Nov; 19(11):1769-77. PubMed ID: 20936417
[TBL] [Abstract][Full Text] [Related]
52. Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review.
Rivera DR; Ganz PA; Weyrich MS; Bandos H; Melnikow J
J Natl Cancer Inst; 2018 Feb; 110(2):. PubMed ID: 28954296
[TBL] [Abstract][Full Text] [Related]
53. Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the St. Jude Lifetime Cohort Study.
Ness KK; Jones KE; Smith WA; Spunt SL; Wilson CL; Armstrong GT; Srivastava DK; Robison LL; Hudson MM; Gurney JG
Arch Phys Med Rehabil; 2013 Aug; 94(8):1451-7. PubMed ID: 23537607
[TBL] [Abstract][Full Text] [Related]
54. Peripheral neurotoxicity following high-dose cisplatin with glutathione: clinical and neurophysiological assessment.
Pirovano C; Balzarini A; Böhm S; Oriana S; Spatti GB; Zunino F
Tumori; 1992 Aug; 78(4):253-7. PubMed ID: 1334604
[TBL] [Abstract][Full Text] [Related]
55. Vitamin C (Ascorbic acid) protects from neuropathy caused by cisplatin, through enhanced heat shock protein-70 and reduced oxidant effect.
Pala EE; Pala HG; Ekmekci S; Erbas O
Rev Assoc Med Bras (1992); 2022 Aug; 68(8):1017-1022. PubMed ID: 36134830
[TBL] [Abstract][Full Text] [Related]
56. Vitamin E for preventing chemotherapy-induced peripheral neuropathy.
Argyriou AA; Kalofonos HP
Support Care Cancer; 2011 May; 19(5):725-6; author reply 727-8. PubMed ID: 21234606
[No Abstract] [Full Text] [Related]
57. Interventions for cisplatin-induced hearing loss in children and adolescents with cancer.
Freyer DR; Brock P; Knight K; Reaman G; Cabral S; Robinson PD; Sung L
Lancet Child Adolesc Health; 2019 Aug; 3(8):578-584. PubMed ID: 31160205
[TBL] [Abstract][Full Text] [Related]
58. Neurotoxicity caused by the treatment with platinum analogues.
Amptoulach S; Tsavaris N
Chemother Res Pract; 2011; 2011():843019. PubMed ID: 22312559
[TBL] [Abstract][Full Text] [Related]
59. A systematic review for prevention of cisplatin-induced nephrotoxicity using different hydration protocols and meta-analysis for magnesium hydrate supplementation.
Li J; Wu Y; Chen C; Zhang W; Yue L; Liu T
Clin Exp Nephrol; 2024 Jan; 28(1):1-12. PubMed ID: 37530867
[TBL] [Abstract][Full Text] [Related]
60. Effects of calcium and magnesium on acute and chronic neurotoxicity caused by oxaliplatin: A meta-analysis.
Ao R; Wang YH; Li RW; Wang ZR
Exp Ther Med; 2012 Nov; 4(5):933-937. PubMed ID: 23226752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
